Mirae: SeedAI-driven continuous care platform for autoimmune disease and other complex chronic conditionsOct 4, 2026RoundOSMiraeCompany profile and funding historySourcesprnewswire.comMore in HealthtechMetriport · Series AProFound Therapeutics · StrategicArintra · Series BAISeed · AIBiotechUnited KingdomSeed · United KingdomEnterprise softwareHealthtechEuropeSeed